Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment

Clin Exp Ophthalmol. 2017 Dec;45(9):932. doi: 10.1111/ceo.12991. Epub 2017 Jun 21.

Authors

Michael Tsatsos^{1

2

3

4}, Cheryl MacGregor², Ioannis Athanasiadis³, Marilita M Moschos⁴, Sazan Jameel⁵, Parwez Hossain², David Anderson²

Affiliations

¹ Royal Eye Infirmary, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
² Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
³ Moorfields Eye Hospital NHS Foundation Trust, London, UK.
⁴ University of Athens, Athens, Greece.
⁵ Hawler Medical University, Erbil, Iraq.

PMID: 28544103
DOI: 10.1111/ceo.12991

No abstract available

Publication types

Letter
Comment

MeSH terms

Acyclovir
Administration, Oral
Administration, Topical
Antiviral Agents*
Humans
Keratitis, Herpetic*
Simplexvirus

Substances

Antiviral Agents
Acyclovir